This article compares how women and their relationship to HIV has changed since the original publication of this article in 1990. The number of women infected with HIV has continued to rise, but, in contrast, there have been few changes in their management. We review transmission risks and manifestations of the infection, and also discuss the issues faced by women with HIV.
BradbeerC. HIV and its relationship to women. Int J STD AIDS1990;1:233–8
2.
FowlerMGMelnickSLMathiesonBJ. Women and HIV epidemiology and global review. Obstet Gynecol Clin N Am1997;24:705–29
3.
FernandoSS. Risk factors for HIV-1 infection in Guinea Bissau (Abstract no. THC565). 6th International Conference on AIDS,San Francisco, 1990.
4.
Low-BeerNTaylorGP. Women and HIV infection in the UK: A microcosm of a global problem. J HIV Therapy1998;3:5–8
5.
PlummerFASimonsenINCameronDW. Co-factors in male to female sexual transmission of HIV. J Infect Dis1991;163:233–9
6.
ForestBD. Women HIV and mucosal immunity. Lancet1991;337:835–6
7.
LeynaertBDownsAMde VincenziI. Heterosexual transmission of HIV—variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV. Am J Epidemiol1998;148:88–96
8.
DownsAMde VincenziI. Probability of heterosexual transmission of HIV: Relationship to the number of unprotected sexual contacts. J AIDS Hum Retrovirol1996;11:388–95
9.
HolmbergSD. Biological factors in the sex of HIV. HIV160:116–25
10.
MalambaSSWagnerHVMaudaGOkangoM. Risk factors for HIV infection in rural Ugandan community. AIDS1994;8:253–7
11.
TanferKSergiO. Intercourse during menstruation and self-repeated STD history amongst women. STD1996;23:395–401
12.
AlexanderNJ. Sexual transmission of HIV virus entry into male and female genital tract. WHO global program on AIDS. Fertil Steril1990;54:1–18
13.
BevierPChiassanMAHeffernanRTCastroKG. Women at a STD clinic also reported same-sex contact — their HIV seroprevalence and risk behaviours. Am J Public Health1995;85:1366–71
14.
RaiteriRForaR. Lesbian sex and the risk of HIV transmission. AIDS1998;12:450–1
15.
BlochMCarrAVasakECunninghamPSmithD. The use of HIV PEP after artificial insemination. Am J Obstet Gynecol1999;181:760–1
16.
MacaulayLKitzingerJGreenGWrightD. Unconventional conceptions. AIDS Care1995;7:261–76
17.
TranscosoARRomaniACavranzaCMMaciasJKMasiniR. Probable HIV transmission by female homosexual contact. Medicina (Buenos Aires)1995;55:334–6
18.
EverittRBJimersonGK. The rape victim—a review of 117 consecutive cases. Obstet Gynaecol1977;50:88–90
19.
MurphySMKitchenVHarrisJRWForsterSM. Rape and subsequent seroconversion to HIV. BMJ1989;299:718
20.
BambergerJDWaldoCRGerberdingJLKatzMH. PEP for HIV infection following several assaults (review). Am J Med1999;106:323–6
21.
ZierlerSWitbeckBMayerK. Sexual violence against women living with or at risk from HIV infection. Am J Prev Med1996;12:304–10
22.
WinwoodGMDiClementeRJ. Rape among African Americans—sexual, physiologic and social correlates predisposing to risk of STD/HIV. J Women's Health1998;7:77–84
23.
ToomeyC. Speak no evil, see no shame. Sunday Times Magazine, 28 November 1999.
24.
SwissSGillerJE. Rape as a crime of war. A medical perspective. JAMA1993;270:612–15
25.
de RuiterABrockiehurstP. HIV infection and pregnancy. Int J STD AIDS1998;9:647–55
26.
LewisSReynolds KohlerCFoxHENelsonJA. HIV-1 in trophalastic and vilous Hoglaver cells and haematological pressures in 8 week foetus. Lancet1990;335:565–8
27.
GoedertJDuliegeAArnosCFellonSBiggarR. High risk of HIV-1 infections for first born twins. Lancet1991;338:1471–5
28.
ScottGB. Mothers of infants with HIV. JAMA1985;253:363–6
29.
DunnDTNewellMAdesAEPeckhamCS. Risk of HIV-1 transmission through breastfeeds. Lancet1992;340:585–8
30.
SperlingRSShapiroDECoombsRW. Material viral load zidovudine treatment and the risk of transmission of HIV-1 from mother to infant. N Engl J Med1996;335:1621–9
31.
Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission—Thailand 1996–1998. MMWR1998;47:151–4
32.
European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet1992;339:1007–12
33.
MandelbrotL. Obstetric factors and MCT of HIV—French perinatal Cohorts. Am J Obstet Gynecol1996;175:661–75
34.
NichollA. Antenatal testing. BMJ1998;316:253–8
35.
KreissSNgugiEHolmanK. Efficacy of non-contraceptive sponge use in preventing heterosexual transmission of HIV in Nairobi prostitutes. JAMA1992;268
36.
MostadSOverboughtJDeVangeD. Human contraception, vit A therapy and other risk factors for shedding HIV-infected cells from cervix and vagina. Lancet1997;350:922–7
37.
KapigaSHLyamusaEFLwihulaGKHunterDJ. The incidence of HIV infections amongst women using family planning methods in Dar es Salaam Tanzania. AIDS1998;12:74–85
38.
WangCCKreissJKReillyM. Risk of HIV infection in OCT users—a meta-analysis. J AIDS1999;21:51
39.
SineiSKMansonCSSekadde-Kiganduc AllenMKokonyaD. Complications of use of IUCD amongst HIV-1 infected women. Lancet1998;351:1238–41
40.
MinkoftHLDehovitzJA. Care of women infected with HIV. JAMA1991;23:266
41.
StevensonJM. Survival and progression of HIV disease in women affecting GUM/HIV clinics in Britain and Ireland—MRC Study Group STI75247–252
42.
WardleP. (Abstract 1991). International Conference of AIDS, Florence
43.
EllerbrockTVWrightTCBushTJDolePBridneyKChlassanMA. Characteristics of menstruation in women infected with HIV. Obstet and Gynecol1996;87:1030–4
44.
SaifrinSDattelBJHaverL. Seroprevalence and epidemiological correlates of HIV in women with acute PID. Obstet Gynecol1990;75: 666–701
45.
HankinsCAHandleyMA. HIV disease and AIDS in women. Current knowledge and research agenda. J AIDS1992;5:957–68
46.
KornAPLaundersDV. PID in women. Obstet Gynecol1993;82:765–8
47.
HoesbergBAbulafiaOSealsA. Sexually transmitted diseases and HIV infection among women with PID. Am J Obstet Gynecol1990;163:1135–9
48.
IrwinK. The clinical presentation and course of PID in HIV positive women and HIV negative women (Abstract). 9th International Conference on AIDS,Berlin1993.
49.
CarpenterCJMayerKHSteinMD. HIV infection in North American women: Experience of 240 cases and review of literature. Medicine1991;70:307–25
50.
RhoadsJLWrightDCRedfieldRR. Chronic vaginal candidiasis in women with HIV infection. JAMA1987;257:3105–7
51.
CohenBRPruithithadaN. Relationship between BV and HIV seropositive female commercial sex workers in Chang Mai Thailand (Abstract). First National Conference on Human Retroviruses,Washington1993.
52.
HashemiFBGhassemiMRoebuckKA. Activation of HIV-1 expression by Gardnerella vaginalis. J Infect Dis1999;179:924–30
53.
FennemaJSvan AmeijdenEJCoutinioRA. HIV, STD and gynaecological disorders in women: Increased risk for genital herpes and warts among HIV-infected prostitutes in Amsterdam. AIDS1995;9:1071–8
54.
ColderMPKimSHammerSM. Activation of HIV virus by HSV?J Infect Dis1992;166:494–9
55.
MaierJABergmanARossMG. AIDS manifested by chronic primary genital herpes. Am J Obstet Gynecol1986;155:756–8
56.
KornAPLaundersDV. Gynaecological disease in women infected with HIV-1 (Review). J AIDS1995;9:361–70
57.
SchaferAFriedmanWMielkeM. Increased frequency of CIN in women infected with HIV is related to the degree of immunosuppression. Am J Obstet Gynecol1991;164:93–9
58.
VongueB. Review of cervical cancer and HIV. Int J STD AIDS2000.
59.
ClarkRABessingerR. Clinical manifestations and predictors of survival of older women infected with HIV. J AIDS1997;15:341–5
60.
NastiGSerrainoDRidolfoAAntinoviA. AIDS associated KS is more aggressive in women—a study of 54 patients. J AIDS1999;20:337–41
61.
CooleyTPHirschharnLRO'KeaneJC. KS in women with AIDS. AIDS1996;10:1221–5
62.
BeralVPetermanTABerkelmanRLJaffeHW. Kaposi's sarcoma amongst persons with AIDS: A sexually transmitted infection. Lancet1990;335:123–8
63.
ChuSYBuehlerJWFlemingPLBerkelmanRL. Epidemiology of reported cases of AIDS in lesbians United States 1980–1989. Am J Public Health1990;80:1380–1
64.
BiggarRJ. Cancer in AIDS—an epidemiological assessment. Seminar Oncol1990;17:251–60
65.
LaussouedKClauvelJ-PFergeuxS. AIDS associated KS in female patients. AIDS1991;5:887–90
66.
SerrainoDFranceschiSdel MasoLLa VecchiaC. HIV transmission and KS amongst European women. AIDS1995;9:971–3
67.
McarthyGAKampmannBNovelliV. Vertical transmission of KS. Arch Dis Child1997;74:455–7
68.
GuthAA. Breast cancer and HIV—what do we know?Am Surgical1999;65:209–11
69.
GalaiNVlahovDMargolickJB. Changes in markers of disease progression in HIV-1 seroconversion—a comparison between cohorts of infecting drug users and homosexual men. J Acquir Immunodefic Dis Syndr Hum Retroviral1995;8:66–70
70.
Pezzoh P Philips AN Dovrucci M et al. for HIV Italian Seroconversion Study Group. Category of exposure to HIV and age in the progression to AIDS—longitudinal study of 1199 people with known dates of seroconversion. BMJ1996;313:583–6
71.
EggerMHirrschelBFrancioliP. Impact of new antiretroviral combination therapies in HIV infected patients: Prospective multicentre study. BMJ1997;315: 1194–9
72.
FarzadegonHHooverDAstembarskiJLylesC. Sex differences in HIV-1 viral load and progression to AIDS. Lancet1998;352:1510–13
73.
KatzensteinDAHammerSMHughesMD. The relation of virologic and immunologic markers to clinical outcomes after NA therapy in HIV-infected adults with CD-4s 200–500 per cubic mm. AIDS clinical trials 175 Virologic Studies. N Engl J Med1996;335:1091–8
74.
ShankerGSara-ThomasMAdamsMR. Oestrogen modulates the expression of TNF alpha mRNA in phorbal ester stimulated human monocytic TMP-1 cells. Lymphokine Cytokine Res1994;13:377–82
75.
BHIVA Guidelines Oct 1999.
76.
LucasGMChaissanREMooreRD. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Am Int Med1999;131:81–7
77.
GervasconiCRidolfoATrificoGSantamcrogioS. Redistribution of body fat in HIV-1 infected women undergoing combined ARV. AIDS1999;13:465–71
78.
DangKCBaussermanLCFlynnMM. Changes in body habitus and serum lipid abnormalities in HIV-1 women on HAART. J AIDS1999;21:107–13
79.
ShaBLBasanCAPottageJC. HIV infection in women—an observational study of clinical characteristics, disease progression and survival for a cohort of women in Chicago. J AIDS1995;8:486–95
80.
Changes in survival rate (PO-604 Abstract). International Conference on AIDS,Berlin1993.
81.
Santorio-LopezGHarrisonLHMoultonL. Gender and survival in Brazil. J AIDS1998;19:403–7
